Cato Laurencin, M.D., Ph.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Fiduciary officer
    Ineligible company: 
    Alkermes
    Topic: 
    Board Member
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Fiduciary officer
    Ineligible company: 
    Mimedx
    Topic: 
    Board Member
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Fiduciary officer
    Ineligible company: 
    HOT-Bone
    Topic: 
    Board Member
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Fiduciary officer
    Ineligible company: 
    Biobind
    Topic: 
    Board Member
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Johnson and Johnson
    Topic: 
    Consultant
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Globus Medical
    Topic: 
    Consultant
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Biorez
    Topic: 
    Patent Royalties
    Date added: 
    06/16/2023
    Relationship end date: 
    06/01/2026
Return to The Charles F. Gregory Memorial Lectureship 2023 (RP2306K)